این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Medical Sciences، جلد ۴۶، شماره ۵، صفحات ۳۷۳-۳۸۲
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Esculetin Alleviates Acute Liver Failure following Lipopolysaccharide/D-Galactosamine in Male C57BL/6 Mice
چکیده انگلیسی مقاله Background: Acute liver failure (ALF) is a fatal clinical situation that rapidly leads to the loss of normal liver function. Esculetin is a natural herbal compound used for the management of various diseases such as cardiovascular and renal disorders. In this study, we evaluated the protective effects of esculetin in a mouse model of ALF.Methods: This article is a report on an experimental study that was conducted at Iran University of Medical Sciences in 2019. Forty-eight male C57BL/6 mice were randomly divided into control, LPS/D-Gal, and LPS/D-Gal+Esculetin (40 mg/kg) groups (n=16 per group). ALF was induced with an intraperitoneal injection of lipopolysaccharide (LPS)/D-galactosamine (D-Gal).The LPS/D-Gal group received a mixture of LPS (50 μg/kg) and D-Gal (400 mg/kg). The LPS/D-Gal+Esculetin group received esculetin by gavage 24 hours and one hour before receiving LPS/D-Gal. Six hours after LPS/D-Gal injection, the mice were sacrificed. Liver injury markers, including alanine aminotransferase (ALT), aspartate transaminase (AST), and alkaline phosphatase (ALP), were measured in the serum. Oxidative stress indices and inflammatory markers such as interleukin-1 beta (IL-1β), IL-6, and tumor necrosis factor-alpha (TNF-α) were measured in hepatic tissue. The histopathology of liver tissue was also assessed. The data were analyzed using one-way ANOVA, followed by the post hoc Tukey test.Results: Esculetin lowered oxidative stress and myeloperoxidase activity (p < 0.001); reduced the serum levels of ALT (P=0.037), AST (P=0.032), and ALP (P=0.004); and decreased the hepatic levels of IL-1β (P=0.002), IL-6 (P=0.004), toll-like receptor 4 (p < 0.001), TNF-α (P=0.003), and nuclear factor-kappa B (p < 0.001) as compared with LPS/D-Gal. Additionally, esculetin ameliorated hepatic tissue injury following LPS/D-Gal challenge. Conclusion: Esculetin can reduce liver injury through the mitigation of oxidative burden, inflammation, and neutrophil infiltration and also exerts hepatoprotective effects against ALF.
کلیدواژه‌های انگلیسی مقاله Liver failure, Acute, Lipopolysaccharides, Inflammation, Oxidative stress
نویسندگان مقاله Seyed-Mahdi Mohamadi-Zarch |
Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Tourandokht Baluchnejadmojarad |
Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Davood Nourabadi |
Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Samira Ramazi |
Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Morteza Nazari-Serenjeh |
Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Mehrdad Roghani |
Neurophysiology Research Center, Shahed University, Tehran, Iran

نشانی اینترنتی https://ijms.sums.ac.ir/article_47354_62940eb949e859e09853acde3e13046d.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات